These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 21039318

  • 1. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G, Perera G, Vigl C, Pickl K, Sinner FM, Bernkop-Schnürch A.
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [Abstract] [Full Text] [Related]

  • 2. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L, Ding J, He C, Cui L, Tang C, Yin C.
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G, Vetter A, Barthelmes J, Rahmat D, Laffleur F, Iqbal J, Perera G, Schlocker W, Dünnhaput S, Augustijns P, Bernkop-Schnürch A.
    Int J Pharm; 2012 May 30; 428(1-2):164-70. PubMed ID: 22421322
    [Abstract] [Full Text] [Related]

  • 4. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop-Schnürch A.
    Int J Pharm; 2011 Apr 15; 408(1-2):191-9. PubMed ID: 21295123
    [Abstract] [Full Text] [Related]

  • 5. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
    Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnürch A.
    J Biomed Mater Res A; 2007 Jul 15; 82(1):1-9. PubMed ID: 17265441
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR, Sharma CP.
    J Control Release; 2009 Apr 17; 135(2):144-51. PubMed ID: 19331862
    [Abstract] [Full Text] [Related]

  • 7. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 8. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
    Sajeesh S, Sharma CP.
    Drug Deliv; 2011 May 24; 18(4):227-35. PubMed ID: 21067275
    [Abstract] [Full Text] [Related]

  • 9. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A, Tozuka Y, Takeuchi H.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):445-51. PubMed ID: 21182939
    [Abstract] [Full Text] [Related]

  • 10. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
    Millotti G, Laffleur F, Perera G, Vigl C, Pickl K, Sinner F, Bernkop-Schnürch A.
    J Pharm Sci; 2014 Oct 18; 103(10):3165-70. PubMed ID: 25139279
    [Abstract] [Full Text] [Related]

  • 11. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S, Sharma CP.
    Int J Pharm; 2006 Nov 15; 325(1-2):147-54. PubMed ID: 16859846
    [Abstract] [Full Text] [Related]

  • 12. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y, Wei W, Lv P, Wang L, Ma G.
    Eur J Pharm Biopharm; 2011 Jan 15; 77(1):11-9. PubMed ID: 20933083
    [Abstract] [Full Text] [Related]

  • 13. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G.
    Biomaterials; 2007 Apr 15; 28(13):2233-43. PubMed ID: 17261330
    [Abstract] [Full Text] [Related]

  • 14. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 15; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 15. Thiomer nanoparticles: stabilization via covalent cross-linking.
    Barthelmes J, Dünnhaupt S, Hombach J, Bernkop-Schnürch A.
    Drug Deliv; 2011 Nov 15; 18(8):613-9. PubMed ID: 22111974
    [Abstract] [Full Text] [Related]

  • 16. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
    Sun W, Mao S, Wang Y, Junyaprasert VB, Zhang T, Na L, Wang J.
    Int J Pharm; 2010 Feb 15; 386(1-2):275-81. PubMed ID: 19958824
    [Abstract] [Full Text] [Related]

  • 17. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
    Bravo-Osuna I, Schmitz T, Bernkop-Schnürch A, Vauthier C, Ponchel G.
    Int J Pharm; 2006 Jun 19; 316(1-2):170-5. PubMed ID: 16580797
    [Abstract] [Full Text] [Related]

  • 18. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 19. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
    Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma CP.
    Acta Biomater; 2010 Aug 13; 6(8):3072-80. PubMed ID: 20144748
    [Abstract] [Full Text] [Related]

  • 20. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
    Millotti G, Samberger C, Fröhlich E, Bernkop-Schnürch A.
    Biomacromolecules; 2009 Nov 09; 10(11):3023-7. PubMed ID: 19821557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.